← Mechanisms of action
Norovirus
ORGANISMNorovirus
Drugs acting on this target (14)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| bivalent gii.4/gi.1 | Immunity, active | experimental | Vaccine | Norovirus immunity, active |
| gi.1/gii.4 bivalent vlp vaccine | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| hil-214 | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| mrna-1403 | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| mrna-1405 | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| norovirus bivalent vlp vaccine | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| quadrivalent recombinant norovirus vaccine | Immunity, active | experimental | Vaccine | Norovirus immunity, active |
| recombinant norovirus hexavalent vaccine | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| renov gi.1-vp1 | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| vxa g1.1 nn-t | Immunity, active | experimental | Vaccine | Norovirus immunity, active |
| vxa g2.4 ns-t | Immunity, active | experimental | Vaccine | Norovirus immunity, active |
| vxa-g1.1-nn | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| vxa-g2.4-ns | Immunity, active | experimental | Vaccine | immunity, active - norovirus |
| norovirus -specific t-cell | Immunity, passive | experimental | Cell therapy | immunity, passive - norovirus |